In order to investigate the effects of laser trabeculoplasty (LT) on diurnal intraocular pressure (IOP) variations in 36 eyes of 30 cases with primary open-angle glaucoma (POAG) in which medical treatment was terminated, the IOP curves, recorded 24 h before as well as 24 h and 12 weeks after LT were compared. Twelve weeks after LT, significant IOP decreases were observed: 36.42% in the mean IOP, 29.77% in the mean peak IOP and 50.04% in the mean pressure range. LT might therefore have beneficial effects on the diurnal IOP variations in cases with POAG.

Keywords:
Primary open-angle glaucoma, Laser trabeculoplasty, Diurnal intraocular pressure variations
1.
David R, Zangwill L, Briscoe D, Dagan M: Diurnal intraocular pressure variations: An analysis of 690 diurnal curves. Br J Ophthalmol 1992;72:280–283.
2.
Greenidge KC, Spaeth GL, Fiol-Silva Z: Effect of argon laser trabeculoplasty on the glaucomatous diurnal curve. Ophthalmology 1983;90:800–804.
3.
Wise JB: Long-term control of adult open-angle glaucoma by argon laser treatment. Ophthalmology 1981;88:197–202.
4.
Wilensky JT, Jampol LM: Laser therapy for open angle glaucoma. Ophthalmology 1981;88:213–217.
5.
Weitzman ED, Henkind P, Leitman M, Hellman L: Correlative 24-hour relationships between intraocular pressure and plasma cortisol in normal subjects and patients with glaucoma. Br J Ophthalmol 1975;59:566–572.
6.
Zeimer RC: Circadian Variations in intraocular pressure; in Ritch R, Shields MB, Krupin T (eds): The Glaucomas. St. Louis, Mosby, 1996, vol. 1, chap 21, pp 429–445.
7.
Guzey M, Tamcelik N, Ermis S: Evaluation of short and long wavelength sensitivity with computerized colored macular threshold tests in primary open-angle glaucoma. MN Oftalmoloji 1996;3:228–236.
8.
Kitazawa Y, Horie T: Diurnal variation of intraocular pressure in primary open-angle glaucoma. Am J Ophthalmol 1975;79:557–566.
9.
Henkind P, Leitman M, Weitzman E: The diurnal curve in man: New observations. Invest Ophthalmol Vis Sci 1973;12:705–707.
10.
Wilensky JT: Diurnal variations in intraocular pressure. Trans Am Ophthalmol Soc 1991;89:758–790.
11.
Weinreb RN, Polansky JR, Kramer SG, Baxter JD: Acute effects of dexamethasone on intraocular pressure in glaucoma. Invest Ophthalmol Vis Sci 1985;26:170–175.
12.
Topper JE, Brubaker RF: Effects of timolol, epinephrine and acetazolamide on aqueous flow during sleep. Invest Ophthalmol Vis Sci 1985;26:1315–1319.
13.
Frampton P, Da Rin D, Brown B: Diurnal variation of intraocular pressure and the overriding effects of sleep. Am J Optom Physiol Opt 1987;64:54–61.
14.
Brown B, Burton P, Mann S, Parisi A: Fluctuations in intraocular pressure with sleep. II. Time course of intraocular pressure decrease after waking from sleep. Ophthalmic Physiol Opt 1988;8:249–252.
15.
Reiss GR, Lee DA, Topper JE, Brubaker RF: Aqueous humor flow during sleep. Invest Ophthalmol Vis Sci 1984;25:776–778.
16.
Zeimer RC, Wilensky JT, Gieser KD: Presence and rapid decline of early morning intraocular pressure peaks in glaucoma patients. Ophthalmology 1990;97:547–550.
17.
Smith J: Diurnal intraocular pressure: Correlation to automated perimetry. Ophthalmology 1985;92:858–862.
18.
Wilensky JT: Self tonometry in the management of glaucoma patients with apparent control of intraocular pressure. Arch Opththalmol 1987;105:1072–1081.
19.
Searle A: Argon laser trabeculoplasty as primary therapy in open angle glaucoma: A long-term follow-up. Glaucoma 1990;12:70–75.
20.
David R, Sachs U: Long-term follow-up of patients with various types of glaucoma and ocular hypertension. Glaucoma 1981;3:323–325.
21.
Minckler DS, Bunt AH, Johnson GW: Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest Ophthalmol Vis Sci 1977;16:426–441.
22.
Elsas T, Junk H, Johnsen H: Diurnal intraocular pressure after successful primary laser trabeculoplasty. Am J Ophthalmol 1991;112:67–69.
23.
Phelps CD, Woolson RF, Kolker AE, Becker B: Diurnal variation in intraocular pressure. Am J Ophthalmol 1974;77:367–377.
24.
Thomas JV, Simmons RJ, Belcher CD: Complication of argon laser trabeculoplasty. Glaucoma 1982;4:50–54.
25.
Bergea B, Svedberg B: Primary argon laser trabeculoplasty vs pilocarpine: Short-term effects. Acta Ophthalmol 1992;70:454–460.
26.
Eryildirim S, Maden A, Gonenç U, Onal A: Argon laser trabeculoplasty in open-angle glaucoma. Turkish Ophthalmological Society XXVII. National Ophthalmology Congress Bull Marmaris, 1993, vol I, pp 1893–1897.
27.
Moriarty AP, McHugh JDA, Spalton DJ, Ffytche TJ: Comparison of the anterior chamber inflammatory response to diode and argon laser trabeculoplasty using a laser flaremeter. Ophthalmology 1993;100:1263–1267.
28.
Tuulonen A: Controlled 5-year follow-up study of laser trabeculoplasty as primary therapy for OAG. Am J Ophthalmol 1987;104:334–338.
29.
Izgi B, Turker G, Bilgin L, Basar D: Argon laser trabeculoplasty in open-angle glaucoma. Turk Oftalmol Gaz 1989;19:425–438.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.